Affinity Asset Advisors, LLC
Filing Date
Global Rank
#1,244
/ 8,603
▲ 284
· as of Mar 2026
Top Industry
Biotechnology
91.0%
3Y Alpha vs SPY
+13.3%
Period ended 3 months ago
Filed May 14, 2026 · 56d
22 quarters · since Dec 2020
Clone Performance
Jul 2023–Jul 2026 · vs SPYHypothetical growth of cloning every reported 13F position and rebalancing on each filing, indexed to the same start.
Cloned portfolio
+141.4%
SPY
+76.0%
Annualised alpha
+13.4%
Max drawdown
−46.0%
Estimate. 13F holdings are quarter-lagged and long-only, so the clone rebalances about 45 days after each period end — when the filing becomes public — and excludes options and short positions. Past performance does not predict future results.
Portfolio Concentration
97 positions · as of Mar 31, 2026 · Δ vs Dec 31, 2025Top Position
6.9%
−0.0 pts
Top 5
26.6%
+0.6 pts
Top 10
42.5%
−0.9 pts
HHI
270
Diversified−12
Portfolio Trend
22 quarters · across all stocks
Sector Breakdown
As of Mar 31, 2026| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 92.4% | $1,739,483,340 |
| Unclassified | 6.9% | $130,068,000 |
| Financial Services | 0.7% | $12,700,000 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increased
25 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| OVID | Ovid Therapeutics Inc. | +3,486,318 | 10,636,318 | $23,612,625 | |
| CATX | Perspective Therapeutics, Inc. | +2,864,582 | 3,164,582 | $13,196,306 | |
| LXEO | Lexeo Therapeutics, Inc. | +1,850,211 | 5,050,211 | $28,988,211 | |
| ERAS | Erasca, Inc. | +1,450,000 | 5,350,000 | $86,563,000 | |
| EPRX | Eupraxia Pharmaceuticals Inc. | +1,289,005 | 1,589,005 | $11,504,396 | |
| ROIV | Roivant Sciences Ltd. | +1,100,000 | 2,800,000 | $77,560,000 | |
| IBIO | iBio, Inc. | +1,050,000 | 3,107,200 | $5,903,680 | |
| CMPS | COMPASS Pathways plc | +908,483 | 1,108,483 | $6,129,910 | |
| CNTA | Centessa Pharmaceuticals plc | +799,448 | 1,400,000 | $55,608,000 | |
| ZURA | Zura Bio Ltd | +750,632 | 2,564,303 | $15,257,602 | |
| ANAB | Anaptysbio, Inc | +495,308 | 940,000 | $34,754,902 | |
| AVR | Anteris Technologies Global Corp. | +425,713 | 912,397 | $5,063,803 | |
| XENE | Xenon Pharmaceuticals Inc. | +425,000 | 1,675,000 | $97,401,250 | |
| COGT | Cogent Biosciences, Inc. | +400,000 | 750,000 | $28,867,500 | |
| ALKS | Alkermes plc. | +350,000 | 1,350,000 | $47,736,000 | |
| STRO | Sutro Biopharma, Inc. | +321,137 | 1,069,519 | $26,641,718 | |
| AVTX | Avalo Therapeutics, Inc. | +289,786 | 1,340,840 | $20,018,741 | |
| DNTH | Dianthus Therapeutics, Inc. /DE/ | +285,000 | 400,000 | $33,568,000 | |
| CLDX | Celldex Therapeutics, Inc. | +150,000 | 500,000 | $15,860,000 | |
| ARWR | Arrowhead Pharmaceuticals, Inc. | +130,000 | 200,000 | $12,540,000 | |
| RVMD | Revolution Medicines, Inc. | +100,000 | 200,000 | $19,450,000 | |
| ASND | Ascendis Pharma A/S | +65,000 | 95,000 | $21,729,350 | |
| APGE | Apogee Therapeutics, Inc. | +50,000 | 1,284,926 | $108,152,221 | |
| BLTE | Belite Bio, Inc | +45,000 | 65,000 | $10,363,600 | |
| INSM | INSMED Inc | +30,000 | 480,000 | $78,489,600 | |
| No positions match the current search. | |||||
Trimmed
Positions the filer reduced
25 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| TSHA | Taysha Gene Therapies, Inc. | −2,300,000 | 1,000,000 | $4,470,000 | |
| WVE | Wave Life Sciences Ltd. | −1,298,273 | 1,401,727 | $10,162,520 | |
| CGEM | Cullinan Therapeutics, Inc. | −1,150,846 | 781,260 | $11,101,704 | |
| RZLT | Rezolute, Inc. | −803,503 | 1,547,641 | $4,720,305 | |
| CLYM | Climb Bio, Inc. | −600,000 | 700,000 | $4,795,000 | |
| QURE | uniQure N.V. | −550,000 | 300,000 | $4,905,000 | |
| KPTI | Karyopharm Therapeutics Inc. | −389,575 | 500,000 | $2,785,000 | |
| ORKA | Oruka Therapeutics, Inc. | −302,669 | 499,673 | $24,508,960 | |
| SVRA | Savara Inc | −285,000 | 2,512,153 | $13,716,355 | |
| SGMT | Sagimet Biosciences Inc. | −280,225 | 868,020 | $4,535,404 | |
| OBIO | Orchestra BioMed Holdings, Inc. | −170,254 | 402,550 | $1,710,837 | |
| BBIO | BridgeBio Pharma, Inc. | −170,000 | 150,000 | $11,139,000 | |
| ACLX | Arcellx, Inc. | −160,961 | 362,764 | $41,652,562 | |
| SYRE | Spyre Therapeutics, Inc. | −153,457 | 1,279,134 | $64,519,518 | |
| TRVI | Trevi Therapeutics, Inc. | −150,000 | 2,000,172 | $23,862,051 | |
| MBX | MBX Biosciences, Inc. | −100,000 | 150,000 | $4,477,500 | |
| IMVT | Immunovant, Inc. | −100,000 | 100,000 | $2,484,000 | |
| ESTA | Establishment Labs Holdings Inc. | −100,000 | 100,000 | $5,678,000 | |
| ABVX | Abivax S.A. | −100,000 | 405,000 | $45,096,750 | |
| CYTK | Cytokinetics Inc | −99,517 | 700,483 | $46,168,834 | |
| JBIO | Jade Biosciences, Inc. | −75,000 | 639,956 | $8,991,381 | |
| ENGN | enGene Therapeutics Inc. | −33,000 | 610,370 | $4,156,619 | |
| NUVL | Nuvalent, Inc. | −22,633 | 300,000 | $30,735,000 | |
| PRAX | Praxis Precision Medicines, Inc. | −15,000 | 170,000 | $54,772,300 | |
| NXTC | NextCure, Inc. | −5,468 | 241,826 | $2,582,701 | |
| No positions match the current search. | |||||
New Positions
Positions the filer opened this quarter
25 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| SPY | Spdr S&P 500 ETF Trust | 200,000 | $130,068,000 | |
| MRNA | Moderna, Inc. | 800,000 | $40,640,000 | |
| ELVN | Enliven Therapeutics, Inc. | 586,904 | $23,006,636 | |
| BMY | Bristol Myers Squibb Co | 300,000 | $18,195,000 | |
| HLXC | Helix Acquisition Corp. III | 1,250,000 | $12,700,000 | |
| DMRA | Damora Therapeutics, Inc. | 450,000 | $11,655,000 | |
| ANRO | Alto Neuroscience, Inc. | 500,000 | $11,240,000 | |
| TYRA | Tyra Biosciences, Inc. | 257,512 | $9,862,709 | |
| IBRX | ImmunityBio, Inc. | 1,250,000 | $9,587,500 | |
| KRRO | Korro Bio, Inc. | 706,904 | $8,002,153 | |
| CRSP | CRISPR Therapeutics AG | 150,000 | $7,135,500 | |
| SGP | SpyGlass Pharma, Inc. | 250,000 | $6,477,500 | |
| NVO | Novo Nordisk A S | 175,000 | $6,431,250 | |
| MANE | Veradermics, Inc | 70,000 | $4,420,500 | |
| GENB | Generate Biomedicines, Inc. | 350,000 | $4,375,000 | |
| CGON | CG Oncology, Inc. | 60,000 | $4,060,800 | |
| RLAY | Relay Therapeutics, Inc. | 400,000 | $3,980,000 | |
| CELC | Celcuity Inc. | 30,000 | $3,424,200 | |
| DTIL | Precision Biosciences Inc | 597,946 | $3,288,703 | |
| SLGL | Sol-Gel Technologies Ltd. | 35,000 | $2,772,700 | |
| EQ | Equillium, Inc. | 1,226,310 | $2,452,620 | |
| SABS | SAB Biotherapeutics, Inc. | 575,000 | $2,202,250 | |
| CORT | Corcept Therapeutics Inc | 50,000 | $2,015,500 | |
| ANL | Adlai Nortye Ltd. | 164,748 | $1,140,056 | |
| ALEC | Alector, Inc. | 500,000 | $1,075,000 | |
| No positions match the current search. | ||||
Sold Out
Positions the filer fully exited
8 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| AMGN | Amgen Inc | 145,000 | $47,459,950 | |
| TNGX | Tango Therapeutics, Inc. | 1,000,000 | $8,860,000 | |
| RCUS | Arcus Biosciences, Inc. | 300,000 | $7,149,000 | |
| SMMT | Summit Therapeutics Inc. | 350,000 | $6,121,500 | |
| ABUS | Arbutus Biopharma Corp | 521,900 | $2,510,339 | |
| GERN | Geron Corp | 1,500,000 | $1,980,000 | |
| RARE | Ultragenyx Pharmaceutical Inc. | 75,000 | $1,725,000 | |
| PCSC | Perceptive Capital Solutions Corp | 50,000 | $651,500 | |
| No positions match the current search. | ||||
97 positions ·
$1,882,251,340 total
· as of Mar 31, 2026
Showing 1–50
of 97 positions by value
· page 1 of 2
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| SPY |
Spdr S&P 500 ETF Trust
|
NEW | 200,000 | $130,068,000 | 6.91% | |
| APGE |
Apogee Therapeutics, Inc.
Healthcare
|
Added | 1,284,926 | $108,152,221 | 5.75% | |
| XENE |
Xenon Pharmaceuticals Inc.
Healthcare
|
Added | 1,675,000 | $97,401,250 | 5.17% | |
| ERAS |
Erasca, Inc.
Healthcare
|
Added | 5,350,000 | $86,563,000 | 4.60% | |
| INSM |
INSMED Inc
Healthcare
|
Added | 480,000 | $78,489,600 | 4.17% | |
| ROIV |
Roivant Sciences Ltd.
Healthcare
|
Added | 2,800,000 | $77,560,000 | 4.12% | |
| SYRE |
Spyre Therapeutics, Inc.
Healthcare
|
Reduced | 1,279,134 | $64,519,518 | 3.43% | |
| CNTA |
Centessa Pharmaceuticals plc
Healthcare
|
Added | 1,400,000 | $55,608,000 | 2.95% | |
| PRAX |
Praxis Precision Medicines, Inc.
Healthcare
|
Reduced | 170,000 | $54,772,300 | 2.91% | |
| ALKS |
Alkermes plc.
Healthcare
|
Added | 1,350,000 | $47,736,000 | 2.54% | |
| CYTK |
Cytokinetics Inc
Healthcare
|
Reduced | 700,483 | $46,168,834 | 2.45% | |
| ABVX |
Abivax S.A.
Healthcare
|
Reduced | 405,000 | $45,096,750 | 2.40% | |
| TEVA |
Teva Pharmaceutical Industries Ltd
Healthcare
|
Held | 1,400,000 | $42,168,000 | 2.24% | |
| ACLX |
Arcellx, Inc.
Healthcare
|
Reduced | 362,764 | $41,652,562 | 2.21% | |
| MRNA |
Moderna, Inc.
Healthcare
|
NEW | 800,000 | $40,640,000 | 2.16% | |
| ANAB |
Anaptysbio, Inc
Healthcare
|
Added | 940,000 | $34,754,902 | 1.85% | |
| DNTH |
Dianthus Therapeutics, Inc. /DE/
Healthcare
|
Added | 400,000 | $33,568,000 | 1.78% | |
| NUVL |
Nuvalent, Inc.
Healthcare
|
Reduced | 300,000 | $30,735,000 | 1.63% | |
| TERN |
Terns Pharmaceuticals, Inc.
Healthcare
|
Added | 562,631 | $29,661,906 | 1.58% | |
| LXEO |
Lexeo Therapeutics, Inc.
Healthcare
|
Added | 5,050,211 | $28,988,211 | 1.54% | |
| COGT |
Cogent Biosciences, Inc.
Healthcare
|
Added | 750,000 | $28,867,500 | 1.53% | |
| MDGL |
Madrigal Pharmaceuticals, Inc.
Healthcare
|
Added | 55,000 | $28,790,850 | 1.53% | |
| STRO |
Sutro Biopharma, Inc.
Healthcare
|
Added | 1,069,519 | $26,641,718 | 1.42% | |
| FBRX |
Forte Biosciences, Inc.
Healthcare
|
Held | 1,011,890 | $26,207,951 | 1.39% | |
| ORKA |
Oruka Therapeutics, Inc.
Healthcare
|
Reduced | 499,673 | $24,508,960 | 1.30% | |
| TRVI |
Trevi Therapeutics, Inc.
Healthcare
|
Reduced | 2,000,172 | $23,862,051 | 1.27% | |
| OVID |
Ovid Therapeutics Inc.
Healthcare
|
Added | 10,636,318 | $23,612,625 | 1.25% | |
| ELVN |
Enliven Therapeutics, Inc.
Healthcare
|
NEW | 586,904 | $23,006,636 | 1.22% | |
| ASND |
Ascendis Pharma A/S
Healthcare
|
Added | 95,000 | $21,729,350 | 1.15% | |
| MLYS |
Mineralys Therapeutics, Inc.
Healthcare
|
Added | 750,000 | $20,317,500 | 1.08% | |
| AVTX |
Avalo Therapeutics, Inc.
Healthcare
|
Added | 1,340,840 | $20,018,741 | 1.06% | |
| RVMD |
Revolution Medicines, Inc.
Healthcare
|
Added | 200,000 | $19,450,000 | 1.03% | |
| BMY |
Bristol Myers Squibb Co
Healthcare
|
NEW | 300,000 | $18,195,000 | 0.97% | |
| PTGX |
Protagonist Therapeutics, Inc
Healthcare
|
Held | 172,125 | $18,141,975 | 0.96% | |
| CLDX |
Celldex Therapeutics, Inc.
Healthcare
|
Added | 500,000 | $15,860,000 | 0.84% | |
| ZURA |
Zura Bio Ltd
Healthcare
|
Added | 2,564,303 | $15,257,602 | 0.81% | |
| NRIX |
Nurix Therapeutics, Inc.
Healthcare
|
Held | 967,620 | $14,998,110 | 0.80% | |
| SVRA |
Savara Inc
Healthcare
|
Reduced | 2,512,153 | $13,716,355 | 0.73% | |
| CATX |
Perspective Therapeutics, Inc.
Healthcare
|
Added | 3,164,582 | $13,196,306 | 0.70% | |
| HLXC |
Helix Acquisition Corp. III
Financial Services
|
NEW | 1,250,000 | $12,700,000 | 0.67% | |
| ARWR |
Arrowhead Pharmaceuticals, Inc.
Healthcare
|
Added | 200,000 | $12,540,000 | 0.67% | |
| DMRA |
Damora Therapeutics, Inc.
Healthcare
|
NEW | 450,000 | $11,655,000 | 0.62% | |
| EPRX |
Eupraxia Pharmaceuticals Inc.
Healthcare
|
Added | 1,589,005 | $11,504,396 | 0.61% | |
| ANRO |
Alto Neuroscience, Inc.
Healthcare
|
NEW | 500,000 | $11,240,000 | 0.60% | |
| BBIO |
BridgeBio Pharma, Inc.
Healthcare
|
Reduced | 150,000 | $11,139,000 | 0.59% | |
| CGEM |
Cullinan Therapeutics, Inc.
Healthcare
|
Reduced | 781,260 | $11,101,704 | 0.59% | |
| BLTE |
Belite Bio, Inc
Healthcare
|
Added | 65,000 | $10,363,600 | 0.55% | |
| WVE |
Wave Life Sciences Ltd.
Healthcare
|
Reduced | 1,401,727 | $10,162,520 | 0.54% | |
| VERA |
Vera Therapeutics, Inc.
Healthcare
|
Held | 250,000 | $10,057,500 | 0.53% | |
| TYRA |
Tyra Biosciences, Inc.
Healthcare
|
NEW | 257,512 | $9,862,709 | 0.52% |